Hearing on “21st Century Cures: Examining Ways to Combat Antibiotic Resistance and Foster New Drug Development," Subcommittee on Health (September 19, 2014)

Documents

Memorandum from Ranking Member Henry A. Waxman to Democratic Members of the Subcommittee on Health

Opening Statement of Ranking Member Henry A. Waxman, as prepared for delivery.

Preliminary Transcript

Witnesses

Panel I
Dr. Janet Woodcock
Director, Center for Drug Evaluation and Research
U.S. Food and Drug Administration (FDA)
Testimony

Panel II
Dr. Kenneth J. Hillan
Chief Executive Officer
Achaogen, Inc.
Testimony

Dr. Barbara E. Murray
President
Infectious Diseases Society of America
Testimony

Kevin Outterson
Professor of Law
Boston University School of Law
Testimony

Dr. Adrian Thomas
Vice President, Global Market Access and Public Health
Janssen Global Services, LLC
Testimony

Allan Coukell
Director, Medical Programs, Pew Health Group
The Pew Charitable Trusts
Testimony

Dr. John H. Powers
Assistant Clinical Professor of Medicine
George Washington University School of Medicine
Testimony

Webcast

Key Documents: 

Memorandum from Ranking Member Henry A. Waxman, "21st Century Cures: Examining Ways to Combat Antibiotic Resistance and Foster New Drug Development" (September 17, 2014).

Statement of Ranking Member Henry A. Waxman, Hearing on “21st Century Cures: Examining Ways to Combat Antibiotic Resistance and Foster New Drug Development," Subcommittee on Health (September 19, 2014).

Preliminary Transcript, Hearing on “21st Century Cures: Examining Ways to Combat Antibiotic Resistance and Foster New Drug Development," Subcommittee on Health (September 19, 2014).

Testimony of Dr. Janet Woodcock, U.S. Food and Drug Administration, Hearing on “21st Century Cures: Examining Ways to Combat Antibiotic Resistance and Foster New Drug Development," Subcommittee on Health (September 19, 2014).

Testimony of Dr. Kenneth Hillan, Achaogen, Inc., Hearing on “21st Century Cures: Examining Ways to Combat Antibiotic Resistance and Foster New Drug Development," Subcommittee on Health (September 19, 2014).

Testimony of Dr. Barbara Murray, Infectious Diseases Society of America, Hearing on “21st Century Cures: Examining Ways to Combat Antibiotic Resistance and Foster New Drug Development," Subcommittee on Health (September 19, 2014).

Testimony of Kevin Outterson, Boston University School of Law, Hearing on “21st Century Cures: Examining Ways to Combat Antibiotic Resistance and Foster New Drug Development," Subcommittee on Health (September 19, 2014).

Testimony of Dr. Adrian Thomas, Janssen Global Services, LLC, Hearing on “21st Century Cures: Examining Ways to Combat Antibiotic Resistance and Foster New Drug Development," Subcommittee on Health (September 19, 2014).

Testimony of Allan Coukell, The Pew Charitable Trusts, Hearing on “21st Century Cures: Examining Ways to Combat Antibiotic Resistance and Foster New Drug Development," Subcommittee on Health (September 19, 2014).

Testimony of Dr. John Powers, George Washington University School of Medicine, Hearing on “21st Century Cures: Examining Ways to Combat Antibiotic Resistance and Foster New Drug Development," Subcommittee on Health (September 19, 2014).